Ivan Bindoff

Dr. Ivan Bindoff

University of Tasmania
+1
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2018 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
JWJuanita L Westbury
Juanita L Westbury
PGPeter Gee
Peter Gee
TLTristan Ling
Tristan Ling
DBDonnamay T Brown
Donnamay T Brown
KFKatherine H Franks
Katherine H Franks
GPGregory M Peterson
Gregory M Peterson
Objective: To assess the impact of a multi‐strategic, interdisciplinary intervention on antipsychotic and benzodiazepine prescribing in residential aged care facilities (RACFs). Design, setting: Pros...

19 November 2011 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
MWMackenzie Williams
Mackenzie Williams
Gregory PetersonGregory Peterson
Gregory Peterson
PTPeter C. Tenni
Peter C. Tenni
IBIvan Bindoff
Ivan Bindoff
ASAndrew C. Stafford
Andrew C. Stafford

1 November 2014 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
IBIvan Bindoff
Ivan Bindoff
TLTristan Ling
Tristan Ling
LBLuke Bereznicki
Luke Bereznicki
JWJuanita Westbury
Juanita Westbury
LCLeanne Chalmers
Leanne Chalmers
RORobert Ollington
Robert Ollington
Objective. To provide a computer-based learning method for pharmacy practice that is as effective as paper-based scenarios, but more engaging and less labor-intensive.Design. We developed a flexible and customizable computer simulation of community pharmacy. Using it, the students would be able to work through scenarios which encapsulate the entirety of a patient presentation. We compared the traditional paper-based teaching method to our computer-based approach using equivalent scenarios. The paper-based group had 2 tutors while the computer group had none. Both groups were given a prescenario and postscenario clinical knowledge quiz and survey.Assessment. Students in the computer-based group had generally greater improvements in their clinical knowledge score, and third-year students using the computer-based method also showed more improvements in history taking and counseling competencies. Third-year students also found the simulation fun and engaging.Conclusion. Our simulation of community pharmacy pr...

5 April 2022 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
WBWoldesellassie M. Bezabhe
Woldesellassie M. Bezabhe
LBLuke Bereznicki
Luke Bereznicki
JRJan Radford
Jan Radford
BWBarbara C. Wimmer
Barbara C. Wimmer
MSMohammed Salahudeen
Mohammed Salahudeen
Gregory PetersonGregory Peterson
Gregory Peterson
Background: We compared the dementia incidence rate between users and nonusers of oral anticoagulants (OACs) in a large cohort of primary care patients with atrial fibrillation. Methods and Results: We performed a retrospective study using an Australia‐wide primary care data set, MedicineInsight. Patients aged ≥18 years and newly diagnosed with atrial fibrillation between January 1, 2010, and December 31, 2017, and with no recorded history of dementia or stroke were included and followed until December 31, 2018. We applied a propensity score for 1:1 pair matching of baseline covariates and Cox regression for comparing the dementia incidence rates for OAC users and nonusers. Data were analyzed for 18 813 patients with atrial fibrillation (aged 71.9±12.6 years, 47.1% women); 11 419 had a recorded OAC prescription for at least 80% of their follow‐up time. During the mean follow‐up time of 3.7±2.0 years, 425 patients (2.3%; 95% CI, 2.1%–2.5%) had a documented diagnosis of dementia. After propensity matching, the incidence of dementia was significantly lower in OAC users (hazard ratio [HR], 0.59; 95% CI, 0.44–0.80; P <0.001) compared with nonusers. Direct‐acting oral anticoagulant users had a lower incidence of dementia than non‐OAC users (HR, 0.49; 95% CI, 0.33–0.73; P <0.001) or warfarin users (HR, 0.46; 95% CI, 0.28–0.74; P =0.002). No significant difference was seen between warfarin users and non‐OAC users (HR, 1.08; 95% CI, 0.70–1.70; P =0.723). Conclusions: In patients with atrial fibrillation, direct‐acting oral anticoagulant use may result in a lower incidence of dementia compared with treatment with either warfarin or no anticoagulant.

30 August 2011 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MWMackenzie Williams
Mackenzie Williams
Gregory PetersonGregory Peterson
Gregory Peterson
PTPeter C Tenni
Peter C Tenni
IBIvan Bindoff
Ivan Bindoff
CCColin Curtain
Colin Curtain
JHJeff D Hughes
Jeff D Hughes
Background: Drug-related problems (DRPs) are a major burden on health care systems. Community pharmacists are ideally placed to detect, prevent, and resolve these DRPs. Objective: To determine the number and nature of DRPs detected and clinical interventions performed by Australian community pharmacists, using an electronic system. Methods: An electronic documentation system was designed and integrated into the existing dispensing software of 186 pharmacies to allow pharmacists to record details about the clinical interventions they performed to prevent or resolve DRPs. Participating pharmacies were randomly allocated to 3 groups: group 1 had documentation software, group 2 had documentation software plus a timed reminder to document interventions, and group 3 had documentation software, a timed reminder, and an electronic decision support prompt. Pharmacists classified DRPs, entered recommendations they made, and estimated the clinical significance of the intervention. An observational substudy that included pharmacies without any documentation software was completed to verify intervention rates. Results: Over 12 weeks, 531 participating pharmacists recorded 6230 clinical interventions from 2,013,923 prescriptions, with a median intervention rate of 0.23% of prescriptions. No significant differences were seen between the 3 groups that used documentation software; as expected, however, the pharmacies that used this software had a significantly higher documentation rate compared to the pharmacies without documentation software. The most common interventions were related to drug selection problems (30.8%) and educational issues (24.4%). Recommendations were often related to a change in therapy (40.0%), and 41.6% of interventions were self-rated as highly significant. Drug groups most commonly subject to an intervention included antibiotics, glucocorticoids, nonsteroidal antiinflammatory drugs, and opioids. Conclusions: The documentation system allowed for the determination of the frequency and types of DRPs, as well as the recommendations made to resolve them In community pharmacy practice. Use of the software, including its electronic prompts, significantly increased the documentation of interventions by pharmacists.

1 December 2016 in JMIR Serious Games
Verified
Journal Article
Open access
IBIvan Bindoff
Ivan Bindoff
KSKristy De Salas
Kristy De Salas
Gregory PetersonGregory Peterson
Gregory Peterson
TLTristan Ling
Tristan Ling
ILIan Lewis
Ian Lewis
SFStuart G Ferguson
Stuart G Ferguson
A multidisciplinary journal on gaming and gamification for health education/promotion, teaching and social change.